The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

Since the wildfires, Dr. Philip Amoils is seeing more patients with bronchitis, chronic sinusitis, congestion and asthma.

For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.

High bilirubin levels increase the risk of developing bilirubin gallstones—a type of gallstone more prevalent in Sickle Cell ...

Ubrelvy and Nurtec are prescription medications taken to treat migraines. Though they share similarities, Ubrelvy is for acute treatment, while Nurtec can be taken for immediate symptom relief.

Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

Though long COVID, or post-acute sequelae of SARS-CoV-2 (PASC), is more common in adults than in kids, 1.3% of US children ...

COURTESY NICK WENDRYCH Drone footage of the Jan. 1 fireworks accident that initially killed three and injured on Keaka Drive in Aliamanu. Four of five remaining Hawaii patients with severe injuries ...

Following recent reports on the rise in corridor care and growing A&E waits, many are concerned by the devastating collapse ...

Health insurance — and its associated business lines — has been a highly lucrative business for the past decade or so. But ...

To help reduce the spread of influenza and other respiratory illnesses, the public is strongly advised to: Wash hands ...

The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...